Incidence of DVT in Hip & knee replacement patients treated by only aspirin & mechanical device - A prospective study of 247 patients

Increase of in number of joint replacement has challenged orthopaedic surgeons with task of balancing the complications of venous thrombo embolism on one side and adverse effects of prophylactic agents like bleeding on other side. Despite numerous studies and extensive clinical experience, the ideal method of venous thromboembolism prophylaxis remains controversial. Aspirin as an agent for deep vein thrombosis prophylaxis after total joint Arthroplasty is safe, inexpensive, does not require blood parameters monitoring and easy to use with excellent patient compliance supplemented with mechanical prophylaxis in the form of DVT pumps, early mobilization and CPM further reduces the chances of DVT. In this view we have decided to study the incidence of DVT in joint replacement patients treated with asiprin and mechanical devices alone, which as shown satisfactory results with non of our patients developing pulmonary embolism with incidence of DVT in our study is as low as 1%.